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Abstract
Creatine has been shown to be neuroprotective in aging, neurodegenerative conditions and brain injury. As a common
molecular background, oxidative stress and disturbed cellular energy homeostasis are key aspects in these conditions.
Moreover, in a recent report we could demonstrate a life-enhancing and health-promoting potential of creatine in rodents,
mainly due to its neuroprotective action. In order to investigate the underlying pharmacology mediating these mainly
neuroprotective properties of creatine, cultured primary embryonal hippocampal and cortical cells were challenged with
glutamate or H2O2. In good agreement with our in vivo data, creatine mediated a direct effect on the bioenergetic balance,
leading to an enhanced cellular energy charge, thereby acting as a neuroprotectant. Moreover, creatine effectively
antagonized the H2O2-induced ATP depletion and the excitotoxic response towards glutamate, while not directly acting as
an antioxidant. Additionally, creatine mediated a direct inhibitory action on the NMDA receptor-mediated calcium response,
which initiates the excitotoxic cascade. Even excessive concentrations of creatine had no neurotoxic effects, so that high-
dose creatine supplementation as a health-promoting agent in specific pathological situations or as a primary prophylactic
compound in risk populations seems feasible. In conclusion, we were able to demonstrate that the protective potential of
creatine was primarily mediated by its impact on cellular energy metabolism and NMDA receptor function, along with
reduced glutamate spillover, oxidative stress and subsequent excitotoxicity.
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Introduction
The protective potential of creatine (1-methyl-guanidino acetic
acid) has been extensively assessed in various models of
neurodegeneration, including in vivo models of oxidative stress
[1,2].
Aging, neurodegenerative diseases like Alzheimer’s disease,
Huntington’s disease and amyotrophic lateral sclerosis, and
potentially also neuropsychiatric disorders like schizophrenia share
some bioenergetic core features, specifically the contribution of
oxidative stress caused by a progressive dysfunction of the
respiratory chain along with mitochondrial DNA damage [3–5].
Thus, as a potential antioxidative agent and buffer of intracellular
energy stores, creatine - specifically in a preventive approach - may
also become an interesting new agent to increase life span and to
delay the progression of the disorders mentioned above.
In neuronal cells, aerobic glycolysis is the primary source for
ATP synthesis [6]. As stores of glucose, glycogen and O2 are
limited in the brain, the availability of the creatine kinase/
phosphocreatine (CK/PCr) system may operate as an important
alternative energy source in tissues or subcellular compartments
with high and fluctuating energy demands, e.g. in neurons [7].
Based on substrate level phosphorylation of adenine with CK/PCr
this system is capable of rapidly restoring ATP levels within certain
limits, determined by the tissue concentrations of creatine/CPK
itself and the enzymatic system required for phosphorylation and
phosphate group transfer. ATP is required to maintain the




ATPase, thus preserving the membrane potential [8]. Considering
that high relative CK activity could be demonstrated in the brain
[9], it has been concluded that this enzyme serves as a key factor in
the CNS energy metabolism. In support of this notion, a direct
correlation between CK flux and brain activity has been provided
by in vivo
31P nuclear magnetic resonance transfer determinations
[10,11]. The brain-specific isoform of the CK (CK-BB) in concert
with a mitochondrial isoform (uMT-CK) and the required
substrates (creatine/PCr) regulate intracellular ATP levels [12].
Via formation of an CK ‘‘energy shuttle’’, CK activity has
moreover been discussed to be directly implicated in neurotrans-
mitter release, maintainance of membrane potentials and
restoration of ion gradients over the membrane after depolariza-
tion [12–14].
Primarily, creatine is synthesized in a two step mechanism via
AGAT (arginine: glycine amidinotransferase) in the kidney and
pancreas [15]. The resultant guanidinoacetate is then shuttled to
the liver, where it is subsequently methylated by GAMT
(guanidinoacetate methyltransferase to result in creatine which
ultimately is actively exported to tissues where it is energetically
required. Loss of GAMT activity results in a well-defined creatine
deficiency syndrome, which is characterized by developmental
delay, neurological dysfunction and mental retardation [16]. In
Huntington’s disease, a further neurodegenerative condition,
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contribute to damage in specifically energy-demanding tissues
such as the brain and the cochlea, where intact energy shuttling
processes are crucial [17]. The endogenous de novo creatine
synthetic activity in the brain is rather low. It is interesting to note,
that GAMT was identified to act as a novel target for p53, which
serves as a further mechanism for metabolic stress adaptation [18].
Under normal conditions dietary intake constitutes about 50% of
the total creatine content of the organism. Moreover, the blood-
brain barrier permits passage of systemically supplemented
creatine to the brain [19], which ultimately reaches the neuronal
cytoplasm via a specific sodium and chloride dependent
transmembrane transporter (CRT) working against a concentra-
tion gradient [20]. We thus speculate, that a specific diet should
serve as an efficient strategy to enhance brain tissue creatine
concentrations and establish an ‘‘energy buffer’’.
In a previous report, we demonstrated that creatine supple-
mentation in mice could increase healthy life span. Beyond a
moderately increased life span, the most favourable effects of
creatine related to neurobehavioral performance, most markedly
in memory tests [21]. In an attempt to gain a better understanding
of these neuroprotective properties on the cellular level, we
conducted a study on a hippocampal cell culture model.
Materials and Methods
Hippocampal embryonal cell culture
Pregnant Long Evans rats (Janvier Breeding Centre, Le Genest
Saint Isle, France) were decapitated under deep CO2 anaesthesia.
The embryos (embryonic day 17/18) were rapidly microdissected
on ice and the hippocampal tissue was dissociated by mechanical
homogenization in a Hank’s balanced salt solution (HBSS)
without Ca
2+ and Mg
2+ buffered with 10 mM HEPES at pH 7.4
and supplemented with 1 mM sodium pyruvate and 4% bovine
serum albumin. The tissue was digested with a HBSS solution
containing 2 mg/ml papain and 1000 kU/ml DNAse I. Debris
was removed by two steps of centrifugation at 800 g for 15 min
each. The resulting cell pellet was resuspended by gentle
trituration through a blue polysterene pipet tip. The live (dye-
exluding) purified cells were counted in a hematocytometer by
mixing 20 ml of the suspension with 20 ml of 0.4% trypan blue
solution, plated at a density of 0.8610
5 cells/48 well plate and
cultivated in a defined medium (Neurobasal with antioxidant-free
B27 supplement and 0.5 mM glutamine, 50 mg/ml gentamycin,
GIBCO BRL, Life Technologies Ltd, Paisley, UK) on L-
ornithine-coated tissue culture dishes (Nalge Nunc International,
Rochester, NY, USA) at 95% air, 5% CO2 in a humidified
incubator. Every 72 h and immediately preceding the experiment
one half of the medium volume was replaced by fresh medium.
Experiments were performed on 15–17 DIV (days in vitro). Cell
culture quality was routinely assessed by viability analyses,
morphological parameters and immunostaining for neuronal
and glial cell markers. Glial cells identified by GFAP immuno-
fluorescence represented ,1% of the total cell population, while
.99% of the cells expressed NeuN and b-3-tubulin (TUJ-1) as
neuronal markers.
Experiments were performed in accordance with the German





6/ml) in calcium buffer (140 mM NaCl,
5m M K C l , 0 . 5m M M g C l 2, 20 mM HEPES, 1 mM CaCl2,
10 mM glucose) were loaded with the ‘‘leakage-resistant’’ dye
Fura PE3-AM (1.25 mM) at 37uC for 40 minutes probenecid to
reduce compartmentalization and dye leakage). Immediately
prior to measurement, after 30 minutes for intracellular deester-
ification cells were transferred to a Perkin-Elmer L50B spectro-
fluorimeter equipped with a temperature controlled cuvette
chamber and allowed to equilibrate to 37uC while gently stirring.
Experiments were started after obtaining stable fluorescence
ratios (R) under dual wavelength excitation (340/380 nm) with a
500 nm emission cut-off wavelength for at least 3 minutes.
Stimulatory agents or DMSO vehicle were injected directly in the
sample. Correction for autofluorescence was performed by
parallel processing of DMSO blank samples. For in situ
calibration of Fura PE 3 fluorescence after each experiment cells
were treated with with 10 mM ionomycin and Rmax was
measured. EGTA (5 mM, 30 mM Tris, pH 8.5) was subsequent-
ly added to obtain Rmin. [Ca
2+]i was then calculated using the
G r y n k i e w i c ze q u a t i o n[ 2 2 ] .
LDH assay
Cell death was assessed by determination of the lactate
dehydrogenase (LDH) leakage from the damaged cells into the
medium supernatant after different time intervals following
treatment using a commercially available kit (CytoTox 96,
Promega, Madison, WI, USA).
Glutamate determination
L-Glutamate was measured by an enzymatic assay according to
the supplier’s instructions (Amplex Red
TM Glutamate assay kit,
Molecular Probes, Eugene, Oregon, USA). Protein concentration
was determined by the Bradford assay (Biorad, Munich,
Germany).
ATP/Phosphocreatine assay
ATP and phosphocreatine as markers of the cellular energy
charge were determined by luciferin-luciferase chemiluminescence
in cell lysates (CellTiter-Glo Luminescent Cell Viability Assay,
Promega, Madison, Wisconsin, USA). Protein concentrations,
determined by the Bradford assay were taken as a reference.
Cell-free chemiluminescent determination of superoxide
scavenging by creatine
Xanthine oxidase (0.025 U/ml) and xanthine (100 mM) were
incubated in PBS in order to yield a continuous superoxide
generator. After addition of lucigenin (bis-N-methylacridinium-
nitrate, 50 mM final concentration) and occurrence of stable
chemiluminescence (CL) signals creatine at rising concentra-
tions was added to the system and CL was recorded in a tube
luminometer. Background CL was simultaneously determined
and subtracted. The specificity of CL for stimulated O2
2
release was verified by adding superoxide dismutase (SOD), the
cell-permeable SOD mimic MnTBAP (manganese[III]tetra-
kis[4-benzoic acid]porphyrin), or the low molecular weight
O2
2 scavenger tiron (4,5-dihydroxy-1,3-benzene-disulfonic
acid).
Statistical analysis
If not otherwise specified, data were analyzed with the SPSS
software version 14.0 (SPSS Inc., Chicago, IL, USA). For
statistical analysis either Student’s t-test or one-way ANOVA
followed by Kruskal-Wallis post hoc test was used were appropriate.
Data are expressed as means +/2 SD in normally distributed
data. P values of ,0.05 were considered as statistically significant
using a two-tailed estimation.
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Creatine does not act as an antioxidant
The antioxidant properties of creatine as a superoxide
scavenger were tested in a cell-free environment employing
xanthine oxidase/xanthine as an enzymatic generator of super-
oxide anions. In this system, creatine added in concentrations up
to 5 mM did not reveal any antioxidant properties. In contrast, a
rise of chemiluminescence was seen after adding creatine,
indicating increased superoxide generation or enhanced life-time
of these species (105.2+/23.1% of control, p=0.009).
Creatine incubation for extended periods does not
induce cytotoxicity
Physiological creatine levels in the CNS are settled in the range
from 10–30 mmol/g wet weight. In our experiments no overt signs
of neurotoxicity like cell detachment, alterations of cellular shape
or retraction of cellular processes could be observed at
concentrations ranging up to 10 mM, even if extending the
incubation period for up to 5 days.
Creatine mediates neuroprotection against excitotoxicity
LDH leakage as a marker of cytotoxicity was dose-dependently
increased under glutamate challenge, along with morphological
alterations including retraction of axonal/dendritic processes and
detachment from the cell culture dishes. Toxicity was substantially
mitigated in cell cultures co-incubated with creatine at 5 mM
concentration, even in the glutamate high-dose range. Under
baseline conditions (no glutamate challenge) cell viability in
hippocampal cultures was not significantly enhanced (Fig. 1).
Creatine enhances the cellular energy charge
Hippocampal cells having been incubated with creatine
contained substantially higher concentrations of ATP/Phospho-
creatine determined under baseline conditions than control cell
cultures. Thus the bioenergetic utilization of creatine was
extremely efficient. Unexpectedly, glutamate concentrations, if
not exceeding 5 mM, did not yield energy depletion but rather led
to enhanced intracellular ATP/phosphocreatine levels This
phenomenon was most pronounced in creatine-supplemented
cells (Fig. 2).
Creatine prevents glutamate spillover but fails to
mediate neuroprotection against experimentally induced
oxidative stress
Hydrogen peroxide (H2O2) was added to the cell culture
supernatant to induce oxidative stress. This condition led to a
depletion of intracellular energy levels after 18 h of incubation
(Fig. 3), along with enhanced LDH release into the supernatant
(Fig. 4). Creatine at a concentration of 5 mM applied 3 h before
H2O2 was added could maintain enhanced intracellular ATP/
phosphocreatine concentrations as long as H2O2 concentrations
remained well below 60 mM. Beyond this concentration energy
levels were not altered by creatine pretreatment (Fig. 3).
Unexpectedly, creatine aggravated H2O2-induced toxicity at high
H2O2 concentrations and failed to reduce LDH release going
along with H2O2 exposure, even at low concentrations (Fig. 4). In
contrast, extracellular glutamate concentrations reflecting an
overflow (and secondary hyperexcitability) which occurs along
with oxidative stress were effectively reduced following creatine
incubation (Fig. 5). Thus, creatine seems to efficiently interfere
Figure 1. Protective effect of creatine in hippocampal cell cultures exposed to glutamate. Hippocampal cells (DIV 17) were incubated
with rising concentrations of glutamate in absence or in presence of 5 mM creatine. After 24 h the LDH release into the cell culture supernatant was
determined. Total protein of the lysed cell monolayer was used as a reference. Data are expressed as arbitrary units per mg protein +/2 standard
deviation. Each data point represents the mean of triplicates. Each experiment was independently performed in triplicate. Statistical analysis was
performed by unpaired Student’s T-test. *denotes statistical significance at a level of p,0.01.
doi:10.1371/journal.pone.0030554.g001
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its initiation. Even under non-stressful baseline conditions
glutamate concentrations remained reduced in creatine-treated
hippocampal cell cultures. These effects were far less pronounced
in mixed cortical cell cultures (data not shown). As glial cells were
almost absent in our model the popular explanation for the H2O2
induced glutamate excess as an inhibition of redox-sensitive
glutamate transporters leading to secondary pathology [23] seems
to reflect only one partial aspect of the molecular mechanisms.
The discrepancy between stabilization against secondary gluta-
mate spillover and enhanced H2O2 toxicity in presence of creatine
remains to be investigated. We tend to speculate that H2O2
neurotoxicity is not always necessarily due to the secondary
glutamate excess, which was efficiently antagonized here.
Creatine attenuates the Ca
2+ response following NMDA
receptor stimulation
Following 18 h preincubation with 5 mM creatine (which
yielded no significant toxicity) and careful washout, the rise of
intracellular Ca
2+ ions in response to NMDA receptor stimulation
at supramaximal doses (1 mM) was almost completely abolished,
while in a non-receptor mediated control experiment the response
to addition of the SERCA (sarcoplasmic/endoplasmic reticulum
calcium ATPase) inhibitor thapsigargin (500 nM), which leads to a
depletion of intracellular Ca
2+ stores was largely preserved (Fig. 6).
Discussion
Depletion of high-energy phosphates, such as ATP and
phosphocreatine (PCr) is an early event in the neurotoxicity of
glutamate [24–27]. Abnormal calcium uptake into mitochondria
has also been reported following exposure to glutamate [28–29].
Profound disruption of the cellular energy ultimately leads to a
decreased GTP concentration [30] along with altered activity of
GTP binding proteins, such as Rac and Ras, which yields a
proapoptotic state [31]. Juravleva et al. [32] hypothesized that the
maintainance of the cellular energy charge by creatine may shift
the apoptotic balance towards the Ras-mediated antiapoptotic
PI3K/AKT or survival signal pathways (PI3K/Rac/NAD(P)H-
oxidase/ROS/NF-kappaB), specifically the Ras/NFkappaB sys-
tem, where multiple pathways mediating survival converge via
stabilization of GTP levels. Indeed, creatine was shown to
maintain neuronal/glial survival following glutamate treatment,
which correlated with decreased levels of farnesylated Ras and the
NF-kappaB inhibitor IkappaB and increased levels of ROI [32].
Extending our in vivo data on creatine as a neuroprotective and
life-enhancing agent [21], we designed a series of in vitro
experiments in order to dissect the underlying pharmacology.
For biochemical analysis, cell culture models carry the advantage
of a reduced biological complexity. This does especially apply to
the case of creatine metabolism. Here, on account of systemic
sources and a complex pharmacokinetics through various body
compartments it would be almost impossible to establish controlled
conditions of creatine supply in a specific concentration range in
vivo. Expression of BB-CK and uMt-CK has previously been
demonstrated to occur as early as embryonic day 14, along with
significant CK activity [33]. Thus the cell culture model we chose
seems suitable to assess the neuroprotective potential of creatine.
As GFAP and NeuN staining revealed that .99% of all cells in the
cultures were neurons, a significant contribution of potential glial
Figure 2. Effect of creatine on intracellular ATP/Phosphocreatine content in hippocampal cells exposed to glutamate. Hippocampal
cells (DIV 17) were challenged with glutamate at rising concentrations in absence or presence of 5 mM creatine. After 24 h of incubation the cells
were harvested and intracellular ATP/PCr concentration was determined by luciferin/luciferase chemiluminescence. Total protein content of the cell
lysate was employed as a reference. Data are expressed as intracellular ATP concentration equivalents corrected for total protein +/2 standard
deviation. Each data point represents the mean of triplicates. The experiment was independently performed in triplicate. Unpaired Student’s T-test
was used for statistics. *denotes statistical significance at a level of p,0.01.
doi:10.1371/journal.pone.0030554.g002
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PLoS ONE | www.plosone.org 4 February 2012 | Volume 7 | Issue 2 | e30554Figure 3. Effect of creatine on intracellular ATP/Phosphocreatine content in hippocampal cells under oxidative stress. Hippocampal
cells (DIV 15) were challenged with hydrogen peroxide at rising concentrations in absence or presence of 5 mM creatine. After 24 h the cells were
harvested for determination of intracellular ATP/PCr concentration, which was determined by luciferin/luciferase chemiluminescence and for
measurement of total protein content, which served as a reference. Data are expressed as intracellular ATP concentration equivalents corrected for
total protein +/2 standard deviation. Each data point represents the mean of triplicates. The experiment was independently performed in triplicate.
Unpaired Student’s T-test was used for statistics. *denotes statistical significance at a level of p,0.01.
doi:10.1371/journal.pone.0030554.g003
Figure 4. Protective effect of creatine in hippocampal cell cultures challenged with oxidative stress. Hippocampal cells (DIV 15) were
incubated with hydrogen peroxide in rising concentrations in absence or in presence of 5 mM creatine. After 24 h the LDH release into the cell
culture supernatant was assessed. Total protein of the cell monolayer was used as a reference. Data are expressed as arbitrary units per mg protein
+/2 standard deviation. Each data point represents the mean of triplicates. Each experiment was independently performed in triplicate. Statistical
analysis was performed by unpaired Student’s T-test. *denotes statistical significance at a level of p,0.01.
doi:10.1371/journal.pone.0030554.g004
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improbable.
Generally speaking, our findings are in line with previous in vitro
studies on neuroblastoma, hippocampal and mixed cerebrocortical
cell cultures, which all have shown the potential of creatine to
prevent glutamate-induced neurotoxicity [7,32]. Still, the under-
lying mechanisms, specifically with reference to a potential
interference with ROI generation as a downstream event in the
excitotoxic pathway remained amazingly elusive.
Moreover, it remained to be clarified, how creatine may
interfere with the glutamate metabolism on a cellular level. It has
been hypothesized that these effects are mediated by supporting
mechanisms involved in the glutamate-glutamine cycle, an activity
with a demand of about 60–80% of the energy derived from
glucose metabolism [34]: Glial glutamate uptake from the synaptic
cleft is primarily performed by GLT-1 [35]. Glutamine synthetase
and glutaminase involved in glutamine transport in the presynap-
tic neuron [36] or oxidation to 2-oxo-glutarate, which enters the
citric acid cycle [36–38] are ATP-dependent, likewise. In our
rodent creatine supplementation study, gene expression analysis
revealed an almost twofold upregulation of the high affinity
glutamate transporter Slc1a3, which should also accelerate the
clearance of excessive extracellular glutamate [21]. It may also be
speculated, that nutrient-sensing pathways, such as mTOR
(Target of Rapamycin) and thereby cell proliferation and
senescence might be directly or indirectly regulated by creatine
[39].
Interestingly, although such glial–cell mediated mechanisms
were practically absent in our cell culture model, we could deliver
direct evidence for a massively improved supply of ATP-bound
energy in isolated hippocampal cells. Not unexpectedly, under
these conditions cells became more resistant to withstand an
excitotoxic challenge with glutamate.
The antioxidant properties of creatine remain another
controversial issue: It is generally maintained that glutamate
toxicity is essentially associated with the excessive generation of
reactive oxygen species as a downstream event, eventually
leading to macromolecule alterations and cytotoxicity. The
data on antioxidant properties of creatine is somewhat
controversial: Lawler et al. [40] were able to deliver evidence
for a direct antioxidant potential [40], a view other authors and
ourselves cannot share: Unexpectedly, performing spin-trap-
ping EPR spectroscopy, Juravleva et al. [32] demonstrated an
augmented EPR superoxide signal when creatine was added to
glutamate-treated cortical/glial cell cultures [32]. We were able
to reproduce these findings in a cell-free environment
employing xanthine oxidase/xanthine as an enzymatic super-
oxide generator. Here, creatine tested in a range up to 5 mM
did not reveal any antioxidant properties, but rather led to a
slightly enhanced chemiluminescence reflecting increased super-
oxide generation or enhanced life-time of these species. These
observations correspond wellw i t ho u ro w ni nv i t r od a t a
suggesting an enhanced cytotoxicity of H2O2 in presence of
creatine.
Paradoxically and in contrast to our own data, the above
mentioned authors could observe better cell viability under these
conditions, drawing the conclusion that the enhanced generation
of oxygen radicals may constitute a decisive factor for the
activation of redox-dependent survival pathways. Interestingly, in
some of our cell preparations H2O2 at very low levels (low
micromolar range) seemed to support hippocampal cell viability
(data not shown).
To our knowledge, our report is the first to deliver evidence for
a direct interference of creatine with the NMDA-receptor
mediated neurotransmission. We were able to demonstrate that
creatine pre-treatment leads to a substantially reduced Ca
2+
Figure 5. Impact of creatine on glutamate efflux into the supernatant in hippocampal cell cultures exposed to hydrogen peroxide.
Hippocampal cells (DIV 15) were incubated with rising concentrations of hydrogen peroxide in absence or in presence of 5 mM creatine. After 24 h
the glutamate release into the cell culture supernatant was enzymatically determined. Total protein of the lysed cell monolayer was used as a
reference. Data are expressed as glutamate concentration per mg protein +/2 standard deviation. Each data point represents the mean of triplicates.
Each experiment was independently performed in triplicate. Statistical analysis was performed by unpaired Student’s T-test. *denotes statistical
significance at a level of p,0.01.
doi:10.1371/journal.pone.0030554.g005
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were made after a thorough creatine washout. Therefore,
permanent alterations of the NMDA receptor must have taken
place throughout the incubation period.
Altogether the anti-aging and neuroprotective effect of creatine
seems to result from multiple single effects, ranging from an
economization of the cellular energy metabolism up to not yet
completely understood antiexcitotoxic effects taking place on the
receptor level or subsequent Ca
2+ mediated pathways, a
phenomenon which deserves further investigation. Although
widely postulated, we found no direct evidence for a direct
antioxidative action of creatine.
Figure 6. Impact of creatine pre-incubation on NMDA-triggered intracellular calcium rise in hippocampal cells. Hippocampal cell
cultures (DIV 18) were incubated with 5 mM of creatine for 18 h. Cells were harvested, dissociated and loaded with FURA PE-3/AM. Ca
2+ ratiometry
was performed in 0.5610
6 cells/ml at 37uC. After stable baseline ratios were achieved NMDA was added and the response was recorded for
400 seconds. Thapsigargin was added for SERCA inhibition. The tracings are representative for 5 individual experiments by calculating curve means.
Data for intracellular Ca
2+ are expressed in arbitrary units. The second tracing shows responses in creatine-pretreated cells, the first one has been
acquired from control cells.
doi:10.1371/journal.pone.0030554.g006
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